Top Vaccines companies in Japan by Return on Assets (ROA)
Japan
# |
Name |
Return on Assets (ROA) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
19.92%
|
Dec. 31, 2023 | USD 9.57 | -3.49% |
|
Japan |
|
| 2 |
11.44%
|
March 31, 2024 | USD 14.33 | -1.63% |
|
Japan |
|
| 3 |
8.91%
|
March 31, 2024 | USD 11.63 | 0.67% |
|
Japan |
|
| 4 |
6.11%
|
March 31, 2024 | USD 9.54 | -0.95% |
|
Japan |
|
| 5 |
5.39%
|
March 31, 2024 | USD 3.51 | 6.45% |
|
Japan |
|
| 6 |
4.37%
|
Dec. 31, 2023 | USD 12.89 | -3.06% |
|
Japan |
|
| 7 |
4.28%
|
March 31, 2024 | USD 24.50 | -0.22% |
|
Japan |
|
| 8 |
0.48%
|
March 31, 2024 | USD 9.47 | 0.08% |
|
Japan |
|
| 9 |
-4.71%
|
Dec. 31, 2023 | USD 2.63 | -0.70% |
|
Japan |
|
| 10 |
-9.53%
|
June 30, 2024 | USD 1.01 | 1.37% |
|
Japan |
|
| 11 |
-15.38%
|
March 31, 2024 | USD 0.92 | -1.38% |
|
Japan |
|
| 12 |
-95.00%
|
Dec. 31, 2023 | USD 3.76 | 2.75% |
|
Japan |
|
| 13 |
-148.53%
|
March 31, 2024 | USD 0.17 | 0.04% |
|
Japan |
Frequently Asked Questions
-
Which Vaccines company in Japan has the highest Return on Assets (ROA) ?
The Vaccines company in Japan with the highest Return on Assets (ROA) is Mizuho Medy Co.,Ltd. (Tokyo Stock Exchange: 4595.T) at 19.92%.
-
Which Vaccines company in Japan has the lowest Return on Assets (ROA) ?
The Vaccines company in Japan with the lowest Return on Assets (ROA) is OncoTherapy Science, Inc. (Tokyo Stock Exchange: 4564.T) at -148.53%.
-
What are the top 10 Vaccines companies in Japan by Return on Assets (ROA) ?
The top 10 Vaccines companies in Japan by Return on Assets (ROA) are Mizuho Medy Co.,Ltd., Shionogi & Co., Ltd., WDB Holdings Co., Ltd., Santen Pharmaceutical Co., Ltd., JCR Pharmaceuticals Co., Ltd., PeptiDream Inc., Kissei Pharmaceutical Co., Ltd., Astellas Pharma Inc., RaQualia Pharma Inc. and Soiken Holdings Inc..
-
What are the bottom 10 Vaccines companies in Japan by Return on Assets (ROA) ?
The bottom 10 Vaccines companies in Japan by Return on Assets (ROA) are OncoTherapy Science, Inc., Oncolys BioPharma Inc., NanoCarrier Co., Ltd., Soiken Holdings Inc., RaQualia Pharma Inc., Astellas Pharma Inc., Kissei Pharmaceutical Co., Ltd., PeptiDream Inc., JCR Pharmaceuticals Co., Ltd. and Santen Pharmaceutical Co., Ltd..
